Texas statute
Tex. Health & Safety Code § 481.203 — Patient participation
Current through 89th Legislature, 2nd Called Session (2025)
Part of Chapter 481: TEXAS CONTROLLED SUBSTANCES ACT, Texas Health and Safety Code.
Full text of Tex. Health & Safety Code § 481.203
Statutory text current through the 89th Legislature, 2nd Called Session (2025). This publication reproduces the official statutory text; it is not the official statutes of the State of Texas.
(a) A person may not be considered for participation as a recipient of tetrahydrocannabinols and their derivatives through a research program unless the person is recommended to a person in charge of an approved research program and the review board by a physician who is licensed by the Texas Medical Board and is attending the person. (b) A physician may not recommend a person for the research program unless the person: (1) has glaucoma or cancer; (2) is not responding to conventional treatment for glaucoma or cancer or is experiencing severe side effects from treatment; and (3) has symptoms or side effects from treatment that may be alleviated by medical use of tetrahydrocannabinols or their derivatives.
Official sources
This reference is informational and is not legal advice.